Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

References

• KabbinavarFFSchulzJMcCleodMAddition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trialJ Clin Oncol2005233697370515738537
   PubMed Web of Science ®Google Scholar
• KabbinavarFHurwitzHIFehrenbacherLPhase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancerJ Clin Oncol200321606512506171
   PubMed Web of Science ®Google Scholar
• HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med20043502335234215175435
   PubMed Web of Science ®Google Scholar
• GiantonioBJCatalanoPJMeropolNJEastern Cooperative Oncology Group Study E3200Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200J Clin Oncol2007251539154417442997
   PubMed Web of Science ®Google Scholar
• BennounaJSastreJArnoldDML18147 Study InvestigatorsContinuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialLancet Oncol201314293723168366
   PubMed Web of Science ®Google Scholar
• ScappaticciFASkillingsJRHoldenSNArterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumabJ Natl Cancer Inst2007991232123917686822
   PubMed Web of Science ®Google Scholar
• NalluriSRChuDKeresztesRZhuXWuSRisk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysisJAMA2008300192277228519017914
   PubMed Web of Science ®Google Scholar
• LeeAYLevineMNButlerGIncidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancerJ Clin Oncol2006241404140816549834
   PubMed Web of Science ®Google Scholar
• VersoMAgnelliGVenous thromboembolism associated with long-term use of central venous catheters in cancer patientsJ Clin Oncol2003213665367514512399
   PubMed Web of Science ®Google Scholar
• MonrealMRaventosALermaRPulmonary embolism in patients with upper extremity DVT associated to venous central lines – a prospective studyThromb Haemost1994725485507878630
   PubMed Web of Science ®Google Scholar
• FagnaniDFranchiRPortaCPOLONORD GroupThrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxisAnn Oncol20071855155517158773
   PubMed Web of Science ®Google Scholar
• CoubanSGoodyearMBurnellMRandomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancerJ Clin Oncol2005234063406915767639
   PubMed Web of Science ®Google Scholar
• KarthausMKretzschmarAKröningHDalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialAnn Oncol20061728929616317012
   PubMed Web of Science ®Google Scholar
• SuenagaMMizunumaNKobayashiKManagement of venous thromboembolism in colorectal cancer patients treated with bevacizumabMed Oncol20102780781419697164
   PubMed Web of Science ®Google Scholar
• MillerKDChapLIHolmesFARandomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerJ Clin Oncol20052379279915681523
   PubMed Web of Science ®Google Scholar
• JohnsonDHFehrenbacherLNovotnyWFRandomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerJ Clin Oncol2004222184219115169807
   PubMed Web of Science ®Google Scholar
• Van CutsemERiveraFBerrySFirst BEAT investigatorsSafety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT studyAnn Oncol2009201842184719406901
   PubMed Web of Science ®Google Scholar
• KozloffMYoodMUBerlinJInvestigators of the BRiTE studyClinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort studyOncologist20091486287019726453
   PubMed Web of Science ®Google Scholar
• CassidyJClarkeSDíaz-RubioEXELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsBr J Cancer2011105586421673685
   PubMed Web of Science ®Google Scholar
• LymanGHKhoranaAAKudererNMAmerican Society of Clinical Oncology Clinical PracticeVenous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol2013312189220423669224
   PubMed Web of Science ®Google Scholar
• KhoranaAAFrancisCWCulakovaEKudererNMLymanGHThromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJ Thromb Haemost2007563263417319909
   PubMed Web of Science ®Google Scholar
• NewmanKAReedWPSchimpffSCBustamanteCIWadeJCHickman catheters in association with intensive cancer chemotherapySupport Care Cancer1993192978143107
   PubMed Web of Science ®Google Scholar
• DrakosPENaglerAOrRGillisSSlavinSEldorALow molecular weight heparin for Hickman catheter – induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantationCancer199270189518981326397
   PubMed Web of Science ®Google Scholar
• LokichJJBeckerBSubclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancyCancer198352158615896616416
   PubMed Web of Science ®Google Scholar
• KöksoyCKuzuAErdenIAkkayaAThe risk factors in central venous catheter-related thrombosisAust NZ J Surg199565796798
   Google Scholar
• CortelezziAMoiaMFalangaACATHEM Study GroupIncidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicenter studyBr J Haematol200512981181715953009
   PubMed Web of Science ®Google Scholar
• VersoMAgnelliGBertoglioSEnoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patientsJ Clin Oncol2005234057406215767643
   PubMed Web of Science ®Google Scholar